Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months ...

The 2024 conference has 28 late-breakers plus plenty of basic and population science. More than anything, it’s a celebration.

China's growing obesity crisis sparks the popularity of strict camps aimed at fat loss for those ... She was one of around 60 ...

Here are the details about Yvette Nicole Brown’s weight loss and how she destigmatized obesity. Overall health is important for her, not a number on the scale!

("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of ...

Heart disease, type 2 diabetes, high blood pressure and obesity were more common and linked to reduced access to healthy ...

China has ranked obesity the sixth leading risk factor for death and disability and ramped up efforts to tackle the issue.

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

Hanmi Pharm. Co., Ltd. has announced promising research results for its novel obesity treatment, HM17321. This groundbreaking drug not only augments fat loss but also significantly increases lean ...

On November 5, 2024, Lipocine Inc. (NASDAQ: LPCN) made a significant presentation at the Obesity Society’s Annual Obesity Week® conference in San Antonio, Texas. The company’s key opinion leader, Dr.

6, with plans to move the assets into clinical trials. Poster presentations of both ADC candidates “drew significant ...